Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.

Kaye, Leanne; Vuong, Vy; Barrett, Meredith A; Boers, Elroy; Guilbert, Theresa

Kaye, Leanne; Vuong, Vy; Barrett, Meredith A; Boers, Elroy; Guilbert, Theresa.

Affiliation

Kaye L; ResMed Science Center, San Diego, CA, USA. leanne.kaye@resmed.com.
Vuong V; ResMed Science Center, San Diego, CA, USA.
Barrett MA; ResMed Science Center, San Diego, CA, USA.
Boers E; ResMed Science Center, Halifax, NS, Canada.
Guilbert T; Department of Pediatrics, University of Cincinnati and Pulmonary Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

NPJ Prim Care Respir Med ; 32(1): 31, 2022 09 02.

Article de En | MEDLINE | ID: mdl-36056022

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Asthme Type d'étude: Diagnostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: NPJ Prim Care Respir Med Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google